After the Paper: Australian Phage Network
We have published and advocated phage therapy [1-7]. Here we describe our effort to build a national consortium aimed at delivering phage therapeutics, in an Australian context.
Building a sustainable phage biobank – trials and tribulations
In an ideal world, a phage biobank would be a facility that serves as a primary research and therapeutic development resource for researchers studying critical infection, as well as to the wider community of infectious diseases, industry and biotech with an interest in critical infection.
